Personal profile
Research interests
Glomerular diseases are a well-recognized cause of chronic kidney disease and end-stage renal disease. These disorders are frequently associated with significant morbidity and mortality due not only to organ damage from the disease process itself, but also toxicities of therapeutic agents, in addition to the much increased risk of cardiovascular mortality. My research is focused on the development of safer and more effective therapies for glomerular diseases while exploring the underlying disease mechanisms, with the goals of improving disease remission rates, long-term kidney outcomes, as well as overall patient outcomes.
Clinical interests
Chronic kidney disease; acute kidney injury; electrolyte disorders; glomerulonephritis, lupus nephritis, vasculitis, proteinuria, hematuria, high blood pressure, hemodialysis vascular access, hemodialysis, peritoneal dialysis
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Results of an International Randomized Controlled Trial (PEXIVAS)
the PEXIVAS Investigators, Fussner, L. A., Flores-Suárez, L. F., Cartin-Ceba, R., Specks, U., Cox, P. G., Jayne, D. R. W., Merkel, P. A., Walsh, M., Paizis, K., Walters, G., Jardine, M., Milton, C., Ibraham, A., Siva, B., Desmond, M., Perkovic, V., Kurtkoti, J., Vilayur, E. & Cass, A. & 181 others, , May 1 2024, In: American journal of respiratory and critical care medicine. 209, 9, p. 1141-1151 11 p.Research output: Contribution to journal › Article › peer-review
Open Access33 Link opens in a new tab Scopus citations -
Association of Systemic Lupus Erythematosus Disease Activity With Choroidal Thickness
Lee, I., Gomez, A. R., Kim, A. H. J., Coble, D. W., Marshall, B., Shah, A., Eisen, S., Apte, R. S. & Li, T., Mar 1 2024, In: Journal of Clinical Rheumatology. 30, 2, p. E58-E62Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids
for the PEXIVAS Investigators, Sep 2024, In: Arthritis and Rheumatology. 76, 9, p. 1431-1438 8 p.Research output: Contribution to journal › Article › peer-review
Open Access20 Link opens in a new tab Scopus citations -
Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy
Barbour, S. J., Fervenza, F. C., Induruwage, D., Brenchley, P. E., Rovin, B., Hladunewich, M. A., Reich, H. N., Lafayette, R., Aslam, N., Appel, G. B., Zand, L., Kiryluk, K., Liu, L., Cattran, D. C., Fervenza, F. C., Lieske, J. C., Leung, N., Erickson, S. B., Radhakrishnan, J. & Bomback, A. & 63 others, , Oct 2023, In: Clinical Journal of the American Society of Nephrology. 18, 10, p. 1283-1293 11 p.Research output: Contribution to journal › Article › peer-review
Open Access39 Link opens in a new tab Scopus citations -
Prescribing Patterns for Sodium-Glucose Cotransporter 2 Inhibitors: A Survey of Nephrologists
Singh, T., Li, T., Mandelbrot, D., Astor, B. C. & Mehr, A. P., Aug 2023, In: Kidney International Reports. 8, 8, p. 1669-1671 3 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations